Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized FMT vs Sterile Fecal Filtrate for Recurrent CDI
NCT03353506Phase 2Completed
- Start
- Feb 2018
- Primary completion
- Jun 2019
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of lyophilized sterile fecal filtrate in recurrent Clostridioides difficile infection (rCDI). Started Feb 2018; status: completed.
02
Drugs
lyophilized sterile fecal filtrate
03
Conditions
recurrent Clostridioides difficile infection (rCDI)
Beyond the preview
Go deeper on NCT03353506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03353506.